Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Unger

Showing results (31-40 of 239) with videos related to

Pageof 24
Sort By:
Current Atherosclerosis Reports|January 23, 2013
Prevention of coronary artery disease: recent advances in the management of hypertensionChiara Recarti, Thomas Unger
Basic & Clinical Pharmacology & Toxicology|January 17, 2004
Vasoactive peptides, their receptors and drug developmentHeike Kusserow, Thomas Unger
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 5, 2014
Aldosterone synthase inhibitors in cardiovascular and renal diseasesPawel Namsolleck, Thomas Unger
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Pharmacoeconomics and quality of life analysis of telmisartan in hypertension treatmentKristin Schmerbach, Thomas Unger
Expert Opinion on Investigational Drugs|April 24, 2012
Angiotensin II type 2 receptor agonists--where should they be applied?Ulrike Muscha Steckelings, Thomas Unger
Current Drug Targets|October 27, 2023
The (Pro)renin Receptor - A Regulatory Nodal Point in Disease NetworksHeiko Funke-Kaiser, Thomas Unger
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 4, 2023
The (pro)renin receptor as a pharmacological target in cardiorenal diseaesHeiko Funke-Kaiser, Thomas Unger
Hypertension (Dallas, Tex. : 1979)|May 13, 2009
Angiotensin receptors and autophagy: live and let dieU Muscha Steckelings, Thomas Unger
The International Journal of Biochemistry & Cell Biology|April 5, 2003
Effect of angiotensin AT2 receptor stimulation on vascular cyclic GMP production in normotensive Wistar Kyoto ratsChristiane Pees, Thomas Unger, Peter Gohlke
Pharmacological Research|July 12, 2017
AT2 receptors in cardiovascular and renal diseasesElena Kaschina, Pawel Namsolleck, Thomas Unger
Pageof 24

Showing results (31-40 of 239) with videos related to

Sort By:
Pageof 24
Current Atherosclerosis Reports|January 23, 2013
Prevention of coronary artery disease: recent advances in the management of hypertensionChiara Recarti, Thomas Unger
Basic & Clinical Pharmacology & Toxicology|January 17, 2004
Vasoactive peptides, their receptors and drug developmentHeike Kusserow, Thomas Unger
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 5, 2014
Aldosterone synthase inhibitors in cardiovascular and renal diseasesPawel Namsolleck, Thomas Unger
Expert Review of Pharmacoeconomics & Outcomes Research|June 10, 2010
Pharmacoeconomics and quality of life analysis of telmisartan in hypertension treatmentKristin Schmerbach, Thomas Unger
Expert Opinion on Investigational Drugs|April 24, 2012
Angiotensin II type 2 receptor agonists--where should they be applied?Ulrike Muscha Steckelings, Thomas Unger
Current Drug Targets|October 27, 2023
The (Pro)renin Receptor - A Regulatory Nodal Point in Disease NetworksHeiko Funke-Kaiser, Thomas Unger
Hypertension Research : Official Journal of the Japanese Society of Hypertension|September 4, 2023
The (pro)renin receptor as a pharmacological target in cardiorenal diseaesHeiko Funke-Kaiser, Thomas Unger
Hypertension (Dallas, Tex. : 1979)|May 13, 2009
Angiotensin receptors and autophagy: live and let dieU Muscha Steckelings, Thomas Unger
The International Journal of Biochemistry & Cell Biology|April 5, 2003
Effect of angiotensin AT2 receptor stimulation on vascular cyclic GMP production in normotensive Wistar Kyoto ratsChristiane Pees, Thomas Unger, Peter Gohlke
Pharmacological Research|July 12, 2017
AT2 receptors in cardiovascular and renal diseasesElena Kaschina, Pawel Namsolleck, Thomas Unger
Pageof 24